Treatment of giant intracranial aneurysms using the Pipeline flow-diverting stent: Long-term results from the International Retrospective Study of the Pipeline Embolization Device (IntrePED) study
Restricted accessResearch articleFirst published online April, 2024
Treatment of giant intracranial aneurysms using the Pipeline flow-diverting stent: Long-term results from the International Retrospective Study of the Pipeline Embolization Device (IntrePED) study
Traditional endovascular treatments of giant intracranial aneurysms are associated with high rates of complications and retreatment. Our objective was to examine the safety and long-term efficacy of the Pipeline Embolization Device for treatment of these aneurysms.
Methods
This retrospective study using the IntrePED database included all patients with giant intracranial aneurysms treated with the Pipeline device between July 2008 and February 2013. Efficacy outcomes were stratified by using the Raymond-Roy Occlusion Classification. Predefined safety outcomes included spontaneous rupture of the target aneurysm; ipsilateral intracranial hemorrhage; ischemic stroke; parent artery stenosis; and sustained cranial neuropathy.
Results
Sixty-six embolizations were performed to treat 63 giant intracranial aneurysms (including 2 ruptured): 49 (77.8%) in the anterior and 14 (22.2%) in the posterior circulation. The median follow-up was 22.4 (0.1–60.5) months. Class I angiographic occlusion was achieved in 72.0% (36/50). The neurological morbidity/mortality rate was 23.8% (15/63), with higher rates in the posterior circulation than in the anterior circulation (22.4% vs. 28.6%). Among seven deaths, five had neurological causes. The procedure-related neurological morbidity and mortality rates were 22.7% (15/66) and 7.6% (5/66), respectively. The spontaneous rupture rate was 4.5% (3/66). Two spontaneous ruptures (1 death), 4/4 postprocedural intracranial hemorrhages, and 6/9 ischemic events occurred within 30 days. In-stent stenosis and new-onset cranial neuropathy were not observed during the angiographic follow-up period.
Conclusions
Although procedure-related neurological morbidity/mortality rates were not insignificant, this study confirms the feasibility and long-term efficacy of the Pipeline Embolization Device to treat giant intracranial aneurysms.
DrakeCG. Giant intracranial aneurysms: experience with surgical treatment in 174 patients. Clin Neurosurg1979; 26: 12–95.
3.
CaramiaFSantoroAPantanoP, et al.Cerebral hemodynamics on MR perfusion images before and after bypass surgery in patients with giant intracranial aneurysms. AJNR Am J Neuroradiol2001; 22: 1704–1710.
4.
JuvelaSPorrasMPoussaK. Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg2000; 93: 379–387.
5.
WiebersDOWhisnantJPHustonJ3rd, et al.Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet2003; 362: 103–110.
6.
IshibashiTMurayamaYUrashimaM, et al.Unruptured intracranial aneurysms: incidence of rupture and risk factors. Stroke2009; 40: 313–316.
7.
KhuranaVGPiepgrasDGWhisnantJP. Ruptured giant intracranial aneurysms. Part I. A study of rebleeding. J Neurosurg1998; 88: 425–429.
8.
LawtonMTSpetzlerRF. Surgical management of giant intracranial aneurysms: experience with 171 patients. Clin Neurosurg1995; 42: 245–266.
BatjerHHFrankfurtAIPurdyPD, et al.Use of etomidate, temporary arterial occlusion, and intraoperative angiography in surgical treatment of large and giant cerebral aneurysms. J Neurosurg1988; 68: 234–240.
11.
DrakeCGPeerlessSJ. Giant fusiform intracranial aneurysms: review of 120 patients treated surgically from 1965 to 1992. J Neurosurg1997; 87: 141–162.
12.
GobinYPVinuelaFGurianJH, et al.Treatment of large and giant fusiform intracranial aneurysms with guglielmi detachable coils. J Neurosurg1996; 84: 55–62.
13.
GruberAKillerMBavinzskiG, et al.Clinical and angiographic results of endosaccular coiling treatment of giant and very large intracranial aneurysms: a 7-year, single-center experience. Neurosurgery1999; 45: 793–803. discussion 803–804.
14.
LawtonMTDaspitCPSpetzlerRF. Technical aspects and recent trends in the management of large and giant midbasilar artery aneurysms. Neurosurgery1997; 41: 513–520. discussion 520–521.
15.
LubiczBGauvritJYLeclercX, et al.Giant aneurysms of the internal carotid artery: endovascular treatment and long-term follow-up. Neuroradiology2003; 45: 650–655.
16.
MawadMECekirgeSCiceriE, et al.Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection. J Neurosurg2002; 96: 474–482.
17.
MolyneuxAKerrRStrattonI, et al.International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet2002; 360: 1267–1274.
18.
SluzewskiMMenovskyTvan RooijWJ, et al.Coiling of very large or giant cerebral aneurysms: long-term clinical and serial angiographic results. AJNR Am J Neuroradiol2003; 24: 257–262.
19.
JahromiBSMoccoJBangJA, et al.Clinical and angiographic outcome after endovascular management of giant intracranial aneurysms. Neurosurgery2008; 63: 662–674. discussion 674–675.
20.
MurayamaYNienYLDuckwilerG, et al.Guglielmi detachable coil embolization of cerebral aneurysms: 11 years’ experience. J Neurosurg2003; 98: 959–966.
21.
LiMHLiYDFangC, et al.Endovascular treatment of giant or very large intracranial aneurysms with different modalities: an analysis of 20 cases. Neuroradiology2007; 49: 819–828.
22.
CantoreGSantoroAGuidettiG, et al.Surgical treatment of giant intracranial aneurysms: current viewpoint. Neurosurgery2008; 63: 279–289. discussion 289–290.
23.
SharmaBSGuptaAAhmadFU, et al.Surgical management of giant intracranial aneurysms. Clin Neurol Neurosurg2008; 110: 674–681.
24.
SughrueMESalonerDRayzVL, et al.Giant intracranial aneurysms: evolution of management in a contemporary surgical series. Neurosurgery2011; 69: 1261–1270. discussion 1270–1271.
25.
PonceFASpetzlerRFHanPP, et al.Cardiac standstill for cerebral aneurysms in 103 patients: an update on the experience at the barrow neurological institute. J Neurosurg2011; 114: 877–884.
26.
NandaASonigABanerjeeAD, et al.Microsurgical management of giant intracranial aneurysms: a single surgeon experience from Louisiana state university, shreveport. World Neurosurg2014; 81: 752–764.
27.
ArreseISarabiaRPintadoR, et al.Flow-diverter devices for intracranial aneurysms: systematic review and meta-analysis. Neurosurgery2013; 73: 193–199. discussion 199–200.
28.
BrinjikjiWMuradMHLanzinoG, et al.Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke2013; 44: 442–447.
29.
SiddiquiAHKanPAblaAA, et al.Complications after treatment with pipeline embolization for giant distal intracranial aneurysms with or without coil embolization. Neurosurgery2012; 71: E509–E513. discussion E513.
30.
KallmesDFHanelRLopesD, et al.International retrospective study of the pipeline embolization device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol2015; 36: 108–115.
31.
FiorellaDKellyMEAlbuquerqueFC, et al.Curative reconstruction of a giant midbasilar trunk aneurysm with the pipeline embolization device. Neurosurgery2009; 64: 212–217. discussion 217.
32.
LylykPMirandaCCerattoR, et al.Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery2009; 64: 632–642. discussion 642–643.
33.
McAuliffeWWycocoVRiceH, et al.Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device. AJNR Am J Neuroradiol2012; 33: 164–170.
34.
SaatciIYavuzKOzerC, et al.Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results. AJNR Am J Neuroradiol2012; 33: 1436–1446.
35.
BecskeTKallmesDFSaatciI, et al.Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology2013; 267: 858–868.
36.
ErtlLHoltmannspotterMPatzigM, et al.Use of flow-diverting devices in fusiform vertebrobasilar giant aneurysms: a report on periprocedural course and long-term follow-up. AJNR Am J Neuroradiol2014; 35: 1346–1352.
37.
FujiiTTeranishiKYatomiK, et al.Long-term follow-up results after flow diverter therapy using the pipeline embolization device for large or giant unruptured internal carotid artery aneurysms: single-center retrospective analysis in the Japanese population. Neurol Med Chir (Tokyo)2021; 62: 19–27.
38.
HanelRAKallmesDFLopesDK, et al.Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results. J Neurointerv Surg2020; 12: 62–66.
39.
NelsonPKLylykPSzikoraI, et al.The pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol2011; 32: 34–40.
40.
BaeHJParkYKChoDY, et al.Predictors of the effects of flow diversion in very large and giant aneurysms. AJNR Am J Neuroradiol2021; 42: 1099–1103.
41.
PeschilloSCaporlinguaARestaMC, et al.Endovascular treatment of large and giant carotid aneurysms with flow-diverter stents alone or in combination with coils: a multicenter experience and long-term follow-up. Oper Neurosurg (Hagerstown)2017; 13: 492–502.
42.
LeonardiMCirilloLToniF, et al.Treatment of intracranial aneurysms using flow-diverting silk stents (BALT): a single centre experience. Interv Neuroradiol2011; 17: 306–315.
43.
ZhouYYangPFFangYB, et al.A novel flow-diverting device (tubridge) for the treatment of 28 large or giant intracranial aneurysms: a single-center experience. AJNR Am J Neuroradiol2014; 35: 2326–2333.
44.
ZhouYYangPFFangYB, et al.Parent artery reconstruction for large or giant cerebral aneurysms using a tubridge flow diverter (PARAT): study protocol for a multicenter, randomized, controlled clinical trial. BMC Neurol2014; 14: 97.
45.
MeyersPMCoonALKanPT, et al.SCENT Trial. Stroke2019; 50: 1473–1479.
